Funded Tech Companies
Kuria Therapeutics
Wondering who provided funding to Kuria Therapeutics? Private investors joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Kuria Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
6834 Cantrell Rd. 1651
Little Rock, AR 72207
USA
Little Rock, AR 72207
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Kuria Therapeutics is developing a novel topical Nrf2 activator for important diseases of the eye and skin. Our lead program (KTX-1161) targets the corneal endothelium, where there is strong biologic evidence that activation of Nrf2 can treat and prevent diseases with high unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/9/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Keith Ward
Chief Medical Officer
Brooks Gentry
Chief Operating Officer
Misty Stevens
Chief Technical Officer
Ralph Henry
VP - Bus. Development
David Flory
Company Investors
Browse more funded tech companies:
Kurbo Health | Kurome Therapeutics
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs